Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker-enhanced Artificial Intelligence Based Pediatric Sepsis Screening Tool Towards Early Recognition and Personalized Therapeutics

NCT05311046 is registered in ClinicalTrials.gov with Computer Technology Associates, Inc. as lead sponsor.

NCT NCT05311046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05311046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker-enhanced Artificial Intelligence Based Pediatric Sepsis Screening Tool Towards Early Recognition and Personalized Therapeutics
Lead sponsor
Computer Technology Associates, Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
March 31, 2029
Enrollment
12,961 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis